Holocene Advisors’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,091
Closed -$266K 736
2022
Q3
$266K Sell
17,091
-1,037,584
-98% -$22.8M ﹤0.01% 755
2022
Q2
$24.2M Buy
1,054,675
+241,471
+30% +$5.17M 0.15% 175
2022
Q1
$20M Buy
813,204
+22,689
+3% +$512K 0.1% 187
2021
Q4
$21.6M Buy
790,515
+269,069
+52% +$9.41M 0.11% 193
2021
Q3
$22.3M Buy
+521,446
New +$23.1M 0.12% 187

Other funds holding DH

Holocene Advisors's DH Position: Q4 2022 in Review

Holocene Advisors sold out of Definitive Healthcare (DH) in Q4 2022, closing a stake of 17,091 shares — an estimated $266K sold.

Holocene Advisors first reported a position in DH in Q3 2021 and held it in 5 quarters. The position peaked at $24.2M in Q2 2022. 136 funds tracked by Wall St. Rank hold DH as of Q4 2022.

  • Holocene Advisors reported no remaining Definitive Healthcare position as of Q4 2022 after selling out during the quarter.
  • Holocene Advisors sold 17,091 Definitive Healthcare shares in Q4 2022, an estimated $266K.
  • Holocene Advisors first reported a position in Definitive Healthcare in Q3 2021 and held it in 5 quarters.
  • Holocene Advisors's Definitive Healthcare position peaked at $24.2M in Q2 2022.
  • 136 funds tracked by Wall St. Rank held Definitive Healthcare as of Q4 2022.

Based on Holocene Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.